YDDL Stock Slumps Over 60%, Records Biggest Intraday Slide In 6 Months After Nasdaq Debut – Everything To Know About The Latest Offering

• The company entered into an agreement with two institutional investors to sell 1.7 million units at $7.50 in the follow-on offering.
• The investors have the option to purchase up to an additional $3 million in units within 45 days of closing on the same terms, the company said.
• YDDL said the lock-up period tied to its IPO has been extended by an additional three months. 

Shares of One and One Green Technologies (YDDL) plunged more than 60% on Friday, marking their steepest intraday drop, as investor sentiment soured following the company’s $13 million follow-on offering.

YDDL shares crashed to their lowest since Jan. 20, 2026. The shares were listed on Nasdaq on Oct. 9, 2025.

Discounted Offering Drags Stock

The company entered into an agreement with two institutional investors to sell 1.7 million units at $7.50 apiece in the follow-on offering. Each unit includes one Class A share and a warrant to buy additional shares. The offer price was a 46% discount to the stock’s closing price of $13.91 on Thursday.

The investors also have the option to purchase up to an additional $3 million worth of units within 45 days of closing on the same terms. The company plans to use the proceeds for working capital and general corporate purposes.

The firm added that the securities are being offered through a prospectus included in the company’s Form F-1 filed with the SEC on March 25, 2026. According to the filing, the company offered up to 2.2 million units at $8.12 apiece. In total, the deal could involve over 3.3 million shares if all warrants are exercised.

Extension Of Lock-Up Period

Separately, YDDL said several key shareholders have agreed to extend their lock-up period tied to its initial public offering by an additional three months beyond the original April 9, 2026, deadline. During this time, they will not sell or transfer their shares. The move helps reduce near-term selling pressure, the company said.

Meanwhile, retail sentiment on Stocktwits changed to ‘bullish’ from ‘extremely bullish’ a day earlier, amid ‘extremely high’ message volumes.

The stock has gained around 9% so far this year.

Read also: Travere Therapeutics, Ligand In Focus As FDA Set To Rule On Filspari Next Week – First FSGS Drug At Stake

For updates and corrections, email newsroom[at]stocktwits[dot]com.